Clinical Trial Update: Effect of APC and Epo on the Inflammatory Response During Sepsis

View source ↗

Summary

A completed clinical trial evaluated the effects of activated protein C and erythropoietin on the inflammatory response in sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Drotrecogin alfa (activated protein C) (drotrecogin alfa)
• Erythropoietin (erythropoietin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Sepsis, Systemic Inflammation | Status: COMPLETED